Â¥
34.66
Sep 30
New Key Statistics Module, Z-Score and F-Score
SZSE:002294 Key Ratios
Market Cap ¥ M | 38,639.54 |
Enterprise Value ¥ M | 37,195.64 |
P/E(ttm) | 65.40 |
PE Ratio without NRI | 60.91 |
Forward PE Ratio | 48.82 |
Price/Book | 4.93 |
Price/Sales | 10.32 |
Price/Free Cash Flow | 134.35 |
Price/Owner Earnings | 474.79 |
Payout Ratio % | 0.88 |
Revenue (TTM) ¥ M | 3,723.00 |
EPS (TTM) ¥ | 0.53 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | -5.90 |
5-y EBITDA Growth Rate % | -7.50 |
y-y EBITDA Growth Rate % | -10.70 |
EV-to-EBIT | 51.80 |
EV-to-EBITDA | 51.80 |
PEG | -- |
Shares Outstanding M | 1,114.82 |
Net Margin (%) | 15.75 |
Operating Margin % | 17.94 |
Pre-tax Margin (%) | 17.38 |
Quick Ratio | 2.31 |
Current Ratio | 2.70 |
ROA % (ttm) | 6.16 |
ROE % (ttm) | 7.38 |
ROIC % (ttm) | 8.73 |
Dividend Yield % | 1.44 |
Altman Z-Score | 13.72 |
SZSE:002294 Number of Guru Trades
SZSE:002294 Volume of Guru Trades
Gurus Latest Trades with SZSE:002294
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002294 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Salubris Pharmaceuticals Co Ltd Insider Transactions
No Available Data